Medistim

Earnings Release • Feb 29, 2016

Results for the 4th quarter and preliminary results for 2015 for Medistim ASA

Results for the 4th quarter and preliminary results for 2015 for Medistim ASA

4th quarter 2015 was the best quarter ever for

Medistim and sales ended at MNOK 74.6 (MNOK 66.1), a

growth of 12.9 %. Sales for 2015 ended at MNOK 251.4

(MNOK 214.8), a growth of 17.0 %. Operating profit

(EBIT) for the quarter ended at MNOK 16.0 (MNOK 14.5).

Operating profit for 2015 ended at MNOK 50.3 (MNOK

43.4).

Sales team in the US is increased with 5 sales

representatives in 2015. Sales in the US increased

with 15.7 % for the quarter and 34.8 % for the year.

Medistim entered a strategic agreement with em-tec in

the 4th quarter. The combined flow and ultrasound

imaging study REQUEST has enrolled >200 patients by

the end of 2015.

The Board suggests a dividend of NOK 1,65 per share

(NOK 1.40)